American Society of Nephrology's Kidney Week
The researchers created the survey to better understand health care providers’ experience with and comfortability with prescribing medication for lupus nephritis, as well as at what time during the disease process they prescribe medication.
To evaluate laboratory parameters during the early course of lupus nephritis and their association with long-term stability of kidney function, the researchers enrolled 433 patients between 2008 and 2017 and evaluated their laboratory results at baseline, 3, 6, and 12 months.
To build on their previous study, the researchers aimed to determine whether CD11b activation suppresses toll-like receptor-dependent proinflammatory signaling by controlling IL-1β, influences IL-1β through another mechanism, or does both.
An analysis of US claims data has identified the health care costs and utilization for patients with a new diagnosis of lupus nephritis.